As for the secondary outcome , we found an overall better outcome in patients enrolled in the Equistasi group : 1 ) significant improvement at T1 on Berg Balance Scale ( +45.0 % , p = .026 ) , Activities-specific Balance Confidence ( +83.7 , p = .004 ) , Falls Efficacy Scale ( -33.3 % , p = .026 ) and PDQ-39 ( -48.8 % , p = .004 ) ; 2 ) sustained improvement at T2 in terms of UPDRS-III , Berg Balance Scales , Time Up and Go and PDQ-39 ; 3 ) significant and sustained reduction of the falls rate .